2023 | Differences in clinical features between focal and extensive types of cystitis glandularis in patients without a previous history of urinary tract malignancy
| INVESTIGATIVE AND CLINICAL UROLOGY |
2023 | Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
| INVESTIGATIVE AND CLINICAL UROLOGY |
2022 | Intravesical Recurrence after Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma Is Associated with Flexible Diagnostic Ureteroscopy, but Not with Rigid Diagnostic Ureteroscopy
| CANCERS |
2022 | Relationship between Androgen Deprivation Therapy and Normal-Tension Glaucoma in Patients with Prostate Cancer: A Nationwide Cohort Study
| YONSEI MEDICAL JOURNAL |
2022 | Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but Not with Vascular Dementia
| WORLD JOURNAL OF MENS HEALTH |
2022 | Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS |
2021 | Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study
| PROSTATE INTERNATIONAL |
2021 | Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer
| BIOMEDICINES |
2021 | Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis
| CANCERS |
2021 | Androgen-deprivation therapy and the risk of newly developed fractures in patients with prostate cancer: a nationwide cohort study in Korea
| SCIENTIFIC REPORTS |
2021 | Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Seasonal variations in overactive bladder drug prescription rates in women: a nationwide population-based study | WORLD JOURNAL OF UROLOGY |
2020 | Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012-2016
| INTERNATIONAL NEUROUROLOGY JOURNAL |
2019 | Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratio | WORLD JOURNAL OF UROLOGY |
2018 | Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate Cancer | JOURNAL OF UROLOGY |